HitGen (SHG: 688222)
HitGen Inc is engaged in drug research and development and provision of technical consultation, technology transfer, and technical services. The company uses DEL technology to provide research and development services for early drug discovery and transfer of new drug R&D projects.
Investment Team
0 team members
No team data available